These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6529371)

  • 1. [Immunological studies on mucocutaneous lymphnode syndrome (Kawasaki disease). I. Plasma inhibitory factor(s) against blastic transformation of lymphocytes--a lack of plasma inhibitory factor(s) against blastic transformation of lymphocytes exposed to streptolysin O].
    Wakiguchi H; Kuramitsu M; Kitamura I
    Arerugi; 1984 Nov; 33(11):978-84. PubMed ID: 6529371
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperreactivity of lymphocytes to streptolysin O and lack of plasma inhibitory factor (s) in patients with mucocutaneous lymphnode syndrome.
    Wakiguchi H; Fujieda M; Matsumoto K; Ohara Y; Wakiguchi A; Shiraishi T; Kurashige T; Kitamura I
    Acta Med Okayama; 1986 Dec; 40(6):285-9. PubMed ID: 3825591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM; Schaffer FM; Myones BL; Yount WJ; Rowe RD; Rubin L; Stein LD; Gelfand EW; Silverman ED
    Prog Clin Biol Res; 1987; 250():175-84. PubMed ID: 3423037
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological abnormalities in Kawasaki disease.
    Okumura K; Jujho K; Yanase Y
    Prog Clin Biol Res; 1987; 250():167-74. PubMed ID: 3423036
    [No Abstract]   [Full Text] [Related]  

  • 5. Analytical studies on immunosuppressive factor(s) in sera from patients with Kawasaki disease using monoclonal antibodies.
    Hirao J; Yoshimura N; Homma N; Kano K
    Prog Clin Biol Res; 1987; 250():541. PubMed ID: 3423067
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the mitogenic and antigenic stimulatory properties of a purified streptolysin O preparation.
    Lea T; Michaelsen TE; Rasmussen AM
    Clin Exp Immunol; 1982 Oct; 50(1):139-47. PubMed ID: 6959749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens in mucocutaneous lymph node syndrome in New England.
    Krensky AM; Berenberg W; Shanley K; Yunis EJ
    Pediatrics; 1981 May; 67(5):741-3. PubMed ID: 7255009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kawasaki disease].
    Lebranchu Y
    Ann Dermatol Venereol; 1993; 120(9):587-8. PubMed ID: 8161111
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro Lymphocyte response to mite antigen in Kawasaki disease (MCLS)].
    Hirota T; Kimoto K; Furusho K
    Arerugi; 1982 Oct; 31(10):1070-3. PubMed ID: 7168650
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological studies on MCLS (Kawasaki disease).
    Yata J
    Jpn J Med Sci Biol; 1979 Aug; 32(4):244. PubMed ID: 529603
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immune system in Kawasaki disease. Study of the 1st case of the disease found in Italy in an adult subject].
    Montella F; Persico L; Recchia O
    Minerva Med; 1985 Apr; 76(14-15):711-6. PubMed ID: 3873027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal increases of serum immunoglobulins and increase of immunoglobulin-bearing peripheral blood lymphocytes in children with Kawasaki disease.
    Kuno-Sakai H; Ohta T; Kikuchi T; Hikino N; Takesue R; Iwagaki H; Takakura I; Kimura M
    Tokai J Exp Clin Med; 1982 Nov; 7(6):661-4. PubMed ID: 7184197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. VIII. Immunological tolerance to S. pyogenes-associated antigens seems essential to induction of MCLS.
    Osawa N; Yamaura N; Ikewaki N; Yashiro K; Akiyama T
    Acta Paediatr Jpn; 1989 Aug; 31(4):462-8. PubMed ID: 2514570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigens and Kawasaki disease.
    Furukawa S; Matsubara T; Yabuta K
    Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
    Storch W; Berger H
    Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current viewpoints in the pathogenesis of Kawasaki disease].
    Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complement system in immunological disease of infants and children. Part 1. The role of the complement system in Kawasaki disease].
    Kaneda Y
    Arerugi; 1983 Jul; 32(7):376-85. PubMed ID: 6639368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mucocutaneous lymph node syndrome of Kawasaki disease. Presentation of a case].
    Zulaica D; Alonso M; Ortega J; Pérez Yarza E; Damiano A
    Rev Clin Esp; 1981 Nov; 163(4):265-7. PubMed ID: 7335936
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoantibodies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)].
    Saji T; Umezawa T; Hashiguchi R; Matsuo N
    Arerugi; 1983 Dec; 32(12):1129-33. PubMed ID: 6678147
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma interleukin-10 levels in Kawasaki disease].
    Hirao J; Hibi S; Andoh T; Ichimura T
    Arerugi; 1996 Apr; 45(4):409-12. PubMed ID: 8687289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.